NCGC 00067819

CAS No. 847163-23-9

NCGC 00067819( NCGC00067819 )

Catalog No. M16148 CAS No. 847163-23-9

NCGC 00067819 is a small molecule compound that potentiates CREB signaling with EC50 of 16 nM in the primary screen and 79 nM in the CHO CRE-β-lactamase confirmation assay.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    NCGC 00067819
  • Note
    Research use only, not for human use.
  • Brief Description
    NCGC 00067819 is a small molecule compound that potentiates CREB signaling with EC50 of 16 nM in the primary screen and 79 nM in the CHO CRE-β-lactamase confirmation assay.
  • Description
    NCGC 00067819 is a small molecule compound that potentiates CREB signaling with EC50 of 16 nM in the primary screen and 79 nM in the CHO CRE-β-lactamase confirmation assay; potentiates cAMP production induced by NKH 477.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NCGC00067819
  • Pathway
    Nuclear Receptor/Transcription Factor
  • Target
    CREB/CBP
  • Recptor
    CREB/CBP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    847163-23-9
  • Formula Weight
    346.408
  • Molecular Formula
    C19H14N4OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=NC2=C(C(=N1)SCC3=NC4=CC=CC=C4N3)OC5=CC=CC=C52
  • Chemical Name
    4-(1H-benzimidazol-2-ylmethylsulfanyl)-2-methyl-[1]benzofuro[3,2-d]pyrimidine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xia M, et al. Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2412-7.
molnova catalog
related products
  • NCGC 00067819

    NCGC 00067819 is a small molecule compound that potentiates CREB signaling with EC50 of 16 nM in the primary screen and 79 nM in the CHO CRE-β-lactamase confirmation assay.

  • Naphthol AS-E

    A cell-permeable inhibitor of the KIX-KID interaction and CREB-mediated gene transcription (IC50=2.26 uM).

  • KG-501

    A small-molecule antagonist of CREB-CBP interaction, inhibits the cAMP-dependent activation of cellular genes via CREB.